MLEC
Moolec Science S.A.
NASDAQ · Healthcare · Biotechnology · LU
$6.93
−2.94%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−6.6x
Market Cap
$14.42M
MomentumView details →
1D Return
−2.94%
YTD Return
+81.68%
RSI (14)
47.8
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−6.6x
Market Cap
$14.42M
RSI (14)
47.8
MomentumView details →
1D Return
−2.94%
YTD Return
+81.68%
SummaryUpdated Jun 1, 2025
Moolec Science SA (NASDAQ:MLEC) is a Luxembourg-based biotechnology company founded in 2008 that specializes in producing animal proteins in plants through a technology called Molecular Farming. The company went public in March 2021 and operates across the United States, Europe, and South America. Moolec represents a disruptive approach in the alternative protein landscape, leveraging the natural efficiency of crops like soybeans and peas to produce traditionally animal-derived proteins through genetic engineering techniques.
Similar companies
Latest newsMore news →
No recent news for MLEC.